185 related articles for article (PubMed ID: 17376040)
1. Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver disease.
Yamamoto M; Iwasa M; Iwata K; Kaito M; Sugimoto R; Urawa N; Mifuji R; Konishi M; Kobayashi Y; Adachi Y
J Gastroenterol Hepatol; 2007 Apr; 22(4):498-503. PubMed ID: 17376040
[TBL] [Abstract][Full Text] [Related]
2. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.
Huang MA; Greenson JK; Chao C; Anderson L; Peterman D; Jacobson J; Emick D; Lok AS; Conjeevaram HS
Am J Gastroenterol; 2005 May; 100(5):1072-81. PubMed ID: 15842581
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of long-term dietary restriction of total calories, fat, iron, and protein in patients with chronic hepatitis C virus.
Iwasa M; Iwata K; Kaito M; Ikoma J; Yamamoto M; Takeo M; Kuroda M; Fujita N; Kobayashi Y; Adachi Y
Nutrition; 2004 Apr; 20(4):368-71. PubMed ID: 15043853
[TBL] [Abstract][Full Text] [Related]
4. Predictors of nonalcoholic steatohepatitis in patients with elevated alanine aminotransferase activity.
Puljiz Z; Stimac D; Kovac D; Puljiz M; Bratanić A; Kovacić V; Kardum D; Bonacin D; Hozo I
Coll Antropol; 2010 Mar; 34 Suppl 1():33-7. PubMed ID: 20402293
[TBL] [Abstract][Full Text] [Related]
5. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.
Hong XZ; Li LD; Wu LM
Clin Exp Pharmacol Physiol; 2007; 34(1-2):27-35. PubMed ID: 17201732
[TBL] [Abstract][Full Text] [Related]
6. High-fat, high-fructose diet induces hepatic iron overload via a hepcidin-independent mechanism prior to the onset of liver steatosis and insulin resistance in mice.
Tsuchiya H; Ebata Y; Sakabe T; Hama S; Kogure K; Shiota G
Metabolism; 2013 Jan; 62(1):62-9. PubMed ID: 22854109
[TBL] [Abstract][Full Text] [Related]
7. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): a cross-sectional study.
Allard JP; Aghdassi E; Mohammed S; Raman M; Avand G; Arendt BM; Jalali P; Kandasamy T; Prayitno N; Sherman M; Guindi M; Ma DW; Heathcote JE
J Hepatol; 2008 Feb; 48(2):300-7. PubMed ID: 18086506
[TBL] [Abstract][Full Text] [Related]
8. Iron overload is associated with hepatic oxidative damage to DNA in nonalcoholic steatohepatitis.
Fujita N; Miyachi H; Tanaka H; Takeo M; Nakagawa N; Kobayashi Y; Iwasa M; Watanabe S; Takei Y
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):424-32. PubMed ID: 19190144
[TBL] [Abstract][Full Text] [Related]
9. Preventive role of genistein in an experimental non-alcoholic steatohepatitis model.
Yalniz M; Bahcecioglu IH; Kuzu N; Poyrazoglu OK; Bulmus O; Celebi S; Ustundag B; Ozercan IH; Sahin K
J Gastroenterol Hepatol; 2007 Nov; 22(11):2009-14. PubMed ID: 17914984
[TBL] [Abstract][Full Text] [Related]
10. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol.
Yasutake K; Nakamuta M; Shima Y; Ohyama A; Masuda K; Haruta N; Fujino T; Aoyagi Y; Fukuizumi K; Yoshimoto T; Takemoto R; Miyahara T; Harada N; Hayata F; Nakashima M; Enjoji M
Scand J Gastroenterol; 2009; 44(4):471-7. PubMed ID: 19058085
[TBL] [Abstract][Full Text] [Related]
11. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.
Zheng S; Hoos L; Cook J; Tetzloff G; Davis H; van Heek M; Hwa JJ
Eur J Pharmacol; 2008 Apr; 584(1):118-24. PubMed ID: 18329014
[TBL] [Abstract][Full Text] [Related]
12. High-fat diet: a trigger of non-alcoholic steatohepatitis? Preliminary findings in obese subjects.
Vilar L; Oliveira CP; Faintuch J; Mello ES; Nogueira MA; Santos TE; Alves VA; Carrilho FJ
Nutrition; 2008; 24(11-12):1097-102. PubMed ID: 18640006
[TBL] [Abstract][Full Text] [Related]
13. Serum ferritin levels do not predict the stage of underlying non-alcoholic fatty liver disease.
Chandok N; Minuk G; Wengiel M; Uhanova J
J Gastrointestin Liver Dis; 2012 Mar; 21(1):53-8. PubMed ID: 22457860
[TBL] [Abstract][Full Text] [Related]
14. Dietary habits and nutrient intake in non-alcoholic steatohepatitis.
Toshimitsu K; Matsuura B; Ohkubo I; Niiya T; Furukawa S; Hiasa Y; Kawamura M; Ebihara K; Onji M
Nutrition; 2007 Jan; 23(1):46-52. PubMed ID: 17140767
[TBL] [Abstract][Full Text] [Related]
15. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement.
Dixon JB; Bhathal PS; O'Brien PE
Obes Surg; 2006 Oct; 16(10):1278-86. PubMed ID: 17059735
[TBL] [Abstract][Full Text] [Related]
16. Effects of N-acetylcysteine on oxidative stress in rats with non-alcoholic steatohepatitis.
Samuhasaneeto S; Thong-Ngam D; Kulaputana O; Patumraj S; Klaikeaw N
J Med Assoc Thai; 2007 Apr; 90(4):788-97. PubMed ID: 17487136
[TBL] [Abstract][Full Text] [Related]
17. Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels.
Wong VW; Wong GL; Tsang SW; Hui AY; Chan AW; Choi PC; Chim AM; Chu S; Chan FK; Sung JJ; Chan HL
Aliment Pharmacol Ther; 2009 Feb; 29(4):387-96. PubMed ID: 19035982
[TBL] [Abstract][Full Text] [Related]
18. Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.
Nobili V; Manco M; Ciampalini P; Alisi A; Devito R; Bugianesi E; Marcellini M; Marchesini G
Clin Ther; 2008 Jun; 30(6):1168-76. PubMed ID: 18640473
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of blood oxidative stress-related parameters in alcoholic liver disease and non-alcoholic fatty liver disease.
Das KS; Balakrishnan V; Mukherjee S; Vasudevan DM
Scand J Clin Lab Invest; 2008; 68(4):323-34. PubMed ID: 18609067
[TBL] [Abstract][Full Text] [Related]
20. Hyperlipidemic chicken as a model of non-alcoholic steatohepatitis.
Ayala I; Castillo AM; Adánez G; Fernández-Rufete A; Pérez BG; Castells MT
Exp Biol Med (Maywood); 2009 Jan; 234(1):10-6. PubMed ID: 18997102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
